Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can one assess whether missing data are missing at random in medical studies?

Richard F Potthoff1, Gail E Tudor, Karen S Pieper

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.

Statistical Methods in Medical Research
|June 14, 2006
PubMed
Summary

New methods for missing data are better but assume data are missing at random (MAR). A new testable assumption, MAR+, can help assess MAR validity, though it often fails in medical studies, highlighting the need to prevent missing data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new score with superior stroke risk prediction in atrial fibrillation: entropy-based information gain approaches in a large nationwide cohort.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS).

American heart journal·2025
Same author

Stroke-bleeding risk score pairings within individuals in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) registry.

International journal of cardiology·2024
Same author

Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry.

International journal of cardiology·2024
Same author

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design.

American heart journal·2024
Same author

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry.

International journal of cardiology. Heart & vasculature·2023

Area of Science:

  • Statistics
  • Biostatistics
  • Medical Research Methodology

Background:

  • Advanced statistical methods like multiple imputation improve missing data handling but often rely on the missing at random (MAR) assumption.
  • The critical step of assessing the validity of the MAR assumption has been largely overlooked due to the lack of direct testing methods.
  • Existing methods for missing data analysis often operate under the MAR assumption, which may not always hold true in real-world scenarios.

Purpose of the Study:

  • To introduce a novel, testable assumption, MAR+, as an alternative to the untestable MAR assumption for missing data analysis.
  • To evaluate the utility of MAR+ in assessing the plausibility of the MAR assumption in non-longitudinal studies.
  • To underscore the importance of preventing missing data rather than solely relying on statistical correction methods.

Related Experiment Videos

Main Methods:

  • Proposed a new assumption, MAR+ (Missing At Random Plus), which is testable and implies MAR under certain conditions.
  • Developed a framework to test the MAR+ assumption, applicable primarily to non-longitudinal study designs.
  • Applied the MAR+ testing approach to five illustrative medical case studies.

Main Results:

  • The MAR+ assumption was found to fail in the majority of the five medical examples analyzed.
  • Inability to reject MAR+ provides support for the MAR assumption, while rejection raises concerns about MAR's validity.
  • Demonstrated that even sophisticated statistical techniques have limitations in correcting for missing data.

Conclusions:

  • The MAR+ assumption provides a valuable, testable proxy for assessing the MAR assumption in certain study types.
  • The frequent failure of MAR+ in medical examples suggests that the MAR assumption may be questionable in many practical applications.
  • Emphasized the critical need for proactive strategies to minimize missing data in medical studies to ensure result integrity.